ABBV AbbVie Inc
- Stocks
- Healthcare
- NYSE: ABBV
Price (delayed)
$197.19
Market cap
$348.35B
P/E Ratio
93.45
Dividend/share
$6.47
EPS
$2.11
Enterprise value
$412.36B
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate
Highlights
ABBV's gross profit is up by 20% year-on-year and by 2% since the previous quarter
The gross margin has grown by 13% YoY
ABBV's P/E is 119% above its 5-year quarterly average of 42.7 and 17% above its last 4 quarters average of 79.8
AbbVie's equity has plunged by 113% from the previous quarter and by 103% YoY
Key stats
What are the main financial stats of ABBV
Market
Valuations
Earnings
Shares outstanding
1.77B
Market cap
$348.35B
Enterprise value
$412.36B
Price to earnings (P/E)
93.45
Price to book (P/B)
N/A
Price to sales (P/S)
5.98
EV/EBIT
74.6
EV/EBITDA
29.89
EV/Sales
7.07
Revenue
$58.33B
Gross profit
$41.37B
Operating income
$10.97B
Net income
$3.76B
EBIT
$5.53B
EBITDA
$13.8B
Free cash flow
$18.24B
Per share
Balance sheet
Liquidity
EPS
$2.11
EPS diluted
$2.1
Free cash flow per share
$10.32
Book value per share
-$0.1
Revenue per share
$32.99
TBVPS
$25.18
Total assets
$137.18B
Total liabilities
$137.32B
Debt
$70.48B
Equity
-$183M
Working capital
-$10.51B
Debt to equity
-385.14
Current ratio
0.74
Quick ratio
0.48
Net debt/EBITDA
4.64
Margins
Efficiency
Dividend
EBITDA margin
23.7%
Gross margin
70.9%
Net margin
6.5%
Operating margin
18.8%
Return on assets
2.7%
Return on equity
142.1%
Return on invested capital
8.4%
Return on capital employed
5.7%
Return on sales
9.5%
Dividend yield
3.28%
DPS
$6.47
Payout ratio
274.2%
ABBV stock price
How has the AbbVie stock price performed over time
Intraday
1.01%
1 week
4.6%
1 month
4.18%
1 year
4.17%
YTD
10.97%
QTD
6.23%
Financial performance
How have AbbVie's revenue and profit performed over time
Revenue
$58.33B
Gross profit
$41.37B
Operating income
$10.97B
Net income
$3.76B
Gross margin
70.9%
Net margin
6.5%
The net margin has declined by 33% year-on-year and by 11% since the previous quarter
The company's net income fell by 30% YoY and by 10% QoQ
ABBV's gross profit is up by 20% year-on-year and by 2% since the previous quarter
The operating margin has declined by 16% year-on-year but it rose by 7% since the previous quarter
Price vs fundamentals
How does ABBV's price correlate with its fundamentals
Growth
What is AbbVie's growth rate over time
Valuation
What is AbbVie stock price valuation
P/E
93.45
P/B
N/A
P/S
5.98
EV/EBIT
74.6
EV/EBITDA
29.89
EV/Sales
7.07
ABBV's P/E is 119% above its 5-year quarterly average of 42.7 and 17% above its last 4 quarters average of 79.8
The EPS has contracted by 30% YoY and by 11% from the previous quarter
AbbVie's equity has plunged by 113% from the previous quarter and by 103% YoY
ABBV's P/S is 25% above its 5-year quarterly average of 4.8
ABBV's revenue is up by 6% year-on-year
Efficiency
How efficient is AbbVie business performance
The ROE has soared by 148% YoY and by 49% from the previous quarter
The ROS has contracted by 41% YoY and by 9% from the previous quarter
AbbVie's ROIC has decreased by 41% YoY and by 9% from the previous quarter
AbbVie's return on assets has decreased by 29% YoY and by 10% QoQ
Dividends
What is ABBV's dividend history
DPS
$6.47
Dividend yield
3.28%
Payout ratio
274.2%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did AbbVie financials performed over time
The quick ratio has contracted by 19% YoY
ABBV's current ratio is down by 9% year-on-year and by 2.6% since the previous quarter
AbbVie's equity has plunged by 113% from the previous quarter and by 103% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.